fbpx
Insight Conference
Speakers
John Schneider, Ph.D.
Elliot Marseille, DrPH, MPP
Charles Raison, M.D.
Tura Patterson, M.A.
Date
11/09/2021
Time
3:15pm - 4:30pm
Location
Track 3: Albrecht Kossel room (Charité)

Event

Panel VI: Assessing the Value of Psychedelic Therapies to Payers and Society

Moderated by: Tura Patterson , M.A.

Psychedelics have a deep history in clinical applications and have recently demonstrated clinical value in a variety of mental illnesses. As the psychedelic clinical value proposition forms, it is also important to understand the economic value proposition.  Demonstrating clinical and economic value is the key to assuring sustained access to these promising treatments. This panel will review the current state of mental health treatment and will describe how psychedelics  can fill some of the existing gaps in care.  The panel will present a conceptual model of the value proposition for psychedelic treatment, and will discuss the challenges and opportunities of conducting economic analyses of emerging psychedelic therapies.  Through a conceptual model and case studies of current cost-effectiveness models using MDMA and psilocybin as examples, we will focus on the following issues in determining the value and impact of psychedelic treatments, including:

  • -Overview of the epidemiology and costs of mental illnesses
  • -Review of limitations of the current standards of care (e.g., treatment ineffectiveness)
  • -Review of recent clinical studies of psychedelics
  • -Conceptual framework for the psychedelic treatment value proposition
  • -Issues in the economic evaluation of psychedelic treatments (including model structure, input data, and quality of life data)
  • -Overview of key supply and access issues

Speakers

CEO

John Schneider, Ph.D.

Avalon Health Economics
View Speaker Profile
Director, Global Initiative for Psychedelic Science Economics

Elliot Marseille, DrPH, MPP

University of California, Berkeley
View Speaker Profile
Distinguished Chair, Director of Clinical & Translational Research

Charles Raison, M.D.

University of Wisconsin, Usona Institute, & Emory Healthcare
View Speaker Profile
Senior Director of Strategic Partnerships

Tura Patterson, M.A.

Usona Institute
View Speaker Profile